Genprex Inc C-Suite Interview with Noble Capital Markets Transcript
(Introduction playing)
Welcome to the C-Suite Series presented by ChannelCheck and NOBLE Capital Markets. NOBLE is an SEC-registered, FINRA-licensed broker dealer and the source of the equity research available on ChannelCheck. Today's interview features Genprex; Nasdaq ticker symbol, GNPX.
NOBLE senior research analyst Robert LeBoyer interviews Genprex's President and CEO, Rodney Varner. Visit channelcheck.com, or click the link in the description for NOBLE's research on Genprex, as well as news and events market data.
And now, here's Robert and Rodney.
Hello. I'm Robert LeBoyer, senior analyst at NOBLE Capital. With me today is Rodney Varner, the CEO of Genprex. A company developing a gene therapy platform for cancer and diabetes.
Welcome, Mr. Varner. Can I ask you to describe a little bit of what you're doing and the markets that you're serving?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
